15 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Data
Article Title
Organization
Pyrazolodiazepine derivatives with agonist activity toward Drosophila RYamide receptor.
Gwangju Institute of Science and Technology
Synthesis and structure-activity relationships of carboxylic acid derivatives of pyridoxal as P2X receptor antagonists.
Gwangju Institute of Science and Technology
Synthesis of potent chemical inhibitors of dynamin GTPase.
Gwangju Institute of Science and Technology
Synthesis and biological evaluation of xanthine derivatives with phenacyl group as tryptophan hydroxylase 1 (TPH1) inhibitors for obesity and fatty liver disease.
Gwangju Institute of Science and Technology
Structure-activity relationship analysis of activity-based probes targeting HTRA family of serine proteases.
Gwangju Institute of Science and Technology
Discovery of indirubin-3'-aminooxy-acetamide derivatives as potent and selective FLT3/D835Y mutant kinase inhibitors for acute myeloid leukemia.
Gwangju Institute of Science and Technology
AI-based prediction of new binding site and virtual screening for the discovery of novel P2X3 receptor antagonists.
Gwangju Institute of Science and Technology
Discovery of orally active indirubin-3'-oxime derivatives as potent type 1 FLT3 inhibitors for acute myeloid leukemia.
Gwangju Institute of Science and Technology
Peripheral Selective Oxadiazolylphenyl Alanine Derivatives as Tryptophan Hydroxylase 1 Inhibitors for Obesity and Fatty Liver Disease.
Gwangju Institute of Science and Technology
A novel indirubin derivative that increases somatic cell plasticity and inhibits tumorigenicity.
Gwangju Institute of Science and Technology
Design, Synthesis, and Biological Evaluation of New Peripheral 5HT
Gwangju Institute of Science and Technology
Identification of new aryl hydrocarbon receptor (AhR) antagonists using a zebrafish model.
Gwangju Institute of Science and Technology
Discovery of Novel Pyruvate Dehydrogenase Kinase 4 Inhibitors for Potential Oral Treatment of Metabolic Diseases.
Gwangju Institute of Science and Technology
